Activation of a c-Jun N-terminal kinase-mediated autophagy pathway attenuates the anticancer activity of gemcitabine in human bladder cancer cells

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Anti-Cancer Drugs

• Publication date

  2017-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1097/CAD.0000000000000499PMID 28430744
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Autophagy is associated with chemoresistance in neuroblastoma

  2016cited by this paper
• Neoadjuvant induction dose-dense MVAC for muscle invasive bladder cancer: efficacy and safety compared with classic MVAC and gemcitabine/cisplatin

  2016cited by this paper
• Autophagy of cytoplasmic bulk cargo does not require LC3

  2016cited by this paper
• Autophagy and Cancer

  2015cited by this paper
• [EFFICACY OF NEOADJUVANT GEMCITABINE AND CISPLATIN IN THE MANAGEMENT OF MUSCLE-INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER].

  2015cited by this paper
• Autophagy Inhibitors as a Potential Antiamoebic Treatment for Acanthamoeba Keratitis

  2015cited by this paper
• Sequential gemcitabine and tamoxifen treatment enhances apoptosis and blocks transformation in bladder cancer cells

  2015cited by this paper
• Multimodal management of muscle-invasive bladder cancer.

  2014cited by this paper
• Cancer statistics, 2014

  2014cited by this paper
• Gemcitabine Induces Poly (ADP-Ribose) Polymerase-1 (PARP-1) Degradation through Autophagy in Pancreatic Cancer

  2014cited by this paper
• The cytoprotective role of gemcitabine-induced autophagy associated with apoptosis inhibition in triple-negative MDA-MB-231 breast cancer cells.

  2014cited by this paper
• Autophagy and cancer.

  2013cited by this paper
• Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment

  2013cited by this paper
• Autophagy: cancer's friend or foe?

  2013cited by this paper
• A JNK-mediated autophagy pathway that triggers c-IAP degradation and necroptosis for anticancer chemotherapy

  2013cited by this paper
• Attenuation of TNFSF10/TRAIL-induced apoptosis by an autophagic survival pathway involving TRAF2- and RIPK1/RIP1-mediated MAPK8/JNK activation

  2012cited by this paper
• Autophagy: a cyto-protective mechanism which prevents primary human hepatocyte apoptosis during oxidative stress.

  2012cited by this paper
• Inhibition of autophagy by 3-MA potentiates cisplatin-induced apoptosis in esophageal squamous cell carcinoma cells

  2011cited by this paper
• The dynamic nature of autophagy in cancer.

  2011cited by this paper
• Autophagy inhibition promotes paclitaxel-induced apoptosis in cancer cells.

  2011cited by this paper
• Mammalian autophagy: core molecular machinery and signaling regulation.

  2010cited by this paper
• Assessment of Apoptosis by Immunohistochemistry to Active Caspase-3, Active Caspase-7, or Cleaved PARP in Monolayer Cells and Spheroid and Subcutaneous Xenografts of Human Carcinoma

  2009cited by this paper
• Autophagy fights disease through cellular self-digestion

  2008cited by this paper
• JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy.

  2008cited by this paper
• Sequence dependent potentiation of gemcitabine by flavopiridol in human breast cancer cells

  2005cited by this paper
• Combination of gemcitabine with cisplatin in the treatment of advanced or metastatic transitional cell carcinoma of urinary tract ( report of 18 cases)

  2005cited by this paper
• Selective cytotoxicity of gemcitabine in bladder cancer cell lines

  2002cited by this paper
• Action of 2',2'-difluorodeoxycytidine on DNA synthesis.

  1991cited by this paper

• Molecular mechanisms and translational advances in bladder cancer: from driver genes to precision therapy

  2025cites this paper
• Survivin (BIRC5): Implications in cancer therapy.

  2024cites this paper
• Hyperthermia-mediated cell death via deregulation of extracellular signal-regulated kinase and c-Jun NH2-terminal kinase signaling

  2024influential citation
• Downregulation of BUBR1 regulates the proliferation and cell cycle of breast cancer cells and increases the sensitivity of cells to cisplatin.

  2023cites this paper
• Role of the JNK Pathway in Bladder Cancer

  2022cites this paper
• 4-Methoxydalbergione Inhibits Bladder Cancer Cell Growth via Inducing Autophagy and Inhibiting Akt/ERK Signaling Pathway

  2022cites this paper
• JNK Signaling Promotes Bladder Cancer Immune Escape by Regulating METTL3-Mediated m6A Modification of PD-L1 mRNA.

  2022cites this paper
• lncRNA RP11-147L13.8 suppresses metastasis and chemo-resistance by modulating the phosphorylation of c-Jun protein in GBC

  2021cites this paper
• Oxidative Stress in Cell Signaling and Cell Fate Determination Under Glucose Starvation

  2021cites this paper
• Glutathione S-Transferases in Cancer

  2021cites this paper
• Anti-cancer potential of persimmon (Diospyros kaki) leaves via the PDGFR-Rac-JNK pathway

  2020cites this paper
• Selective inhibitors for JNK signalling: a potential targeted therapy in cancer

  2020cites this paper
• FOXO3/TRIM22 axis abated the antitumor effect of gemcitabine in non-small cell lung cancer via autophagy induction

  2020cites this paper
• Oblongifolin C reverses GEM resistance via suppressing autophagy flux in bladder cancer cells

  2020cites this paper
• Up-regulation of DRAM2 promotes tolerance of bladder transitional cell carcinoma to gemcitabine

  2020cites this paper
• Characterization of mRNA Expression and Endogenous RNA Profiles in Bladder Cancer Based on The Cancer Genome Atlas (TCGA) Database

  2019cites this paper
• JNK signaling in cancer cell survival

  2019cites this paper
• Attenuation of everolimus-induced cytotoxicity by a protective autophagic pathway involving ERK activation in renal cell carcinoma cells

  2018cites this paper
• RACK1 promotes tumorigenicity of colon cancer by inducing cell autophagy

  2018cites this paper
• Role of ubenimex as an anticancer drug and its synergistic effect with Akt inhibitor in human A375 and A2058 cells

  2018cites this paper
• Hypoxia-induced autophagy promotes gemcitabine resistance in human bladder cancer cells through hypoxia-inducible factor 1α activation.

  2018cites this paper